The algodystrophy, also known as complex regional pain syndrome (CRPS), is a painful disease characterized by erythema, edema, functional impairment, sensory and vasomotor disturbance. The diagnosis of CRPS is based solely on clinical signs and symptoms, and for exclusion compared to other forms of chronic pain. There is not a specific diagnostic procedure; careful clinical evaluation and additional test should lead to an accurate diagnosis.
There are similar forms of chronic pain known as bone marrow edema syndrome, in which is absent the history of trauma or triggering events and the skin dystrophic changes and vasomotor alterations. These incomplete forms are self-limited, and surgical treatment is generally not needed. It is still controversial, if these forms represent a distinct self-limiting entity or an incomplete variant of CRPS.
In painful unexplained conditions such as frozen shoulder, post-operative stiff shoulder or painful knee prosthesis, the algodystrophy, especially in its incomplete forms, could represent the cause.
Algodystrophy is a painful disease characterized by erythema, edema, functional impairment, sensory and vasomotor disturbance. The pathogenic mechanisms are not fully understood and some clinical aspects are still lacking of a whole pathogenetic comprehension, but significant progress in knowledge have been recently achieved.
The internationally recognized term for this syndrome nowadays is Complex Regional Pain Syndrome (CRPS), divided in type I or II, regarding respectively the absence or presence of a neurological lesion.
At the same time, there are other pathological entities, such as bone marrow edema syndrome, transient osteoporosis of the hip and regional migratory osteoporosis, that show common features with CRPS. However, they do not have a clear pathogenetic position and their definitive classification remains uncertain.
In the 17th and 18th century literature, several references can be found and many Authors tried to describe this syndrome historically difficult to contextualize. In 1864, it was presented in detail for the first time by Mitchell et all. They described symptoms as burning pain, swelling, skin color and temperature changes, the intense sensitivity to touch and joint stiffness following peripheral traumatic nerve injury due to distal extremity gunshot wounds in soldiers injured in the American civil war. They coined the term ‘causalgia’ to describe this pain syndrome, which means burning pain, used to describe a particular painful condition often associated to various sensory disturbances that sometimes followed major nerve injury.
Early in the 1900 Sudeck described a pain syndrome with similar symptoms and many of the features of causalgia described by Mitchell developed in an extremity after bone fractures without peripheral nerve injury.
In 1916 Leriche linked the sympathetic nervous system to causalgia, reporting pain relief after surgical sympathectomy.
Evans in 1946 introduced the term reflex sympathetic dystrophy for this syndrome, today one of the most widely accepted term.
Since that time, several researchers contributed to describe this pathological entity and many names have been proposed. In 1993, the International Association for the Study of Pain (IASP), after an evaluation of etiologic and pathophysiological aspects as well as clinical characteristics, developed the nomenclature, complex regional pain syndrome (CRPS), and proposed the IASP diagnostic criteria. The IASP also subdivided the CRPS into subtypes I and II, respectively without or with the presence of clinical signs of major peripheral nerve injury.
However, there is no unanimity on the nosological definition; considering only the Italian scientific production, there are 13 different names for such disorders, 79 can be found in the English literature, and more than 100 in other languages. The new term “complex regional pain syndrome”, is currently the most commonly used.
As previously shown, complex regional pain syndrome is known by various names, such as reflex neurovascular dystrophy, causalgia, algodystrophy, shoulder-hand syndrome, reflex sympathetic dystrophy, Sudeck’s atrophy. It describes a large variety of disorders characterized by induced or spontaneous pain that is disproportionate to the inciting event and associated with autonomic and motor alterations in variable combinations. The pain is continuous (spontaneous or evoked), regional (not in a specific nerve territory) and it usually has a distal predominance of abnormal sensory, motor, vasomotor and trophic findings. The syndrome shows a variable progression. It is often associated with substantial disability, loss of quality of life, and societal-economic costs.
Incidence of CRPS is unclear. In the US 5,5 cases per 100000 person-years. CRPS can occur at any age, but is relatively rare in childhood and adolescence. The age group with the highest incidence is even more variable, ranging from the 4th to the 7th decade of life (11). The incidence increases with age until 70 years old, and 3–4 times more women than men are affected. The upper limb is affected in about 60% of cases whereas the leg in about 40%. Resolution rate differs greatly between studies, ranging from 74% in the first year to 36% within 6 years. Fractures (about 45%), sprain (about 18%), and elective surgery (about 12%) are the most frequently reported triggering events, whereas spontaneous-onset is uncommon (<10% of cases).
CRPS is characterized by the presence of inflammatory changes and signs indicating prominent autonomic involvement in the region of pain. This differentiates it from other forms of chronic pain. The involved limb presents: changes in skin color and temperature, sweating, severe hyperalgesia and allodynia, edema, altered patterns of hair and nail growth, reduced strength, dystonia and tremors. Altered perception and body proprioception may be present, reflected in reduced limb positioning accuracy, delays in recognizing limb laterality, abnormal referred sensations and tactile perception, and altered subjective mental representations of the affected limb. The syndrome is often associated with serious impairments in daily activities and ability to function.
The clinical progression of the disease usually can be divided in 3 clinical phases: an early warm acute stage, with inflammatory signs, sometimes followed by a dystrophic phase characterized by a progressively decrease of the edema; then an atrophic phase can be observed, in which skin atrophy and contractures become prevalent.
Typically starting symptoms arise within weeks from the injury. In the acute phase, the involved limb is extremely painful, erythematous, swollen and warm. Collateral symptoms includes allodynia and hyperalgesia, skin and nail growth changes, muscle weakness. The affected area is confined and does not have the distribution of a specific nerve.
As the disorder persists, often the pain does not decrease but spreads, voluntary motor control is reduced and negative sensory signs (hypoesthesia, hypoalgesia, and hypothermesthesia) can develop. Subsequently, the limb often becomes cold, dusky and sweaty. Myoclonus, tremor and dystonia may also occur. Over time, clinical signs can extend to other body parts and even on the opposite or ipsilateral limb. In a subset of patients, CRPS becomes chronic and after long disease duration (>5 years) other features are sometimes noted, such as urological symptoms, syncope, and even mild cognitive deficits. The acute and dystrophic phase are reversible, whereas the atrophic form, when established, is irreversible.
Because of the enormous clinical variability and the etiological heterogeneity, the diagnosis is not easy. There are many non-standardized diagnostic criteria systems. New diagnostic criteria were codified by the International Association for the Study of Pain (IASP) task force on taxonomy at a consensus workshop in 1994. Subsequent validation research found problems with lack of specificity and potential over-diagnosis using these criteria. Successively in the fall of 2003 in Budapest the diagnostic criteria were reviewed. These more specific diagnostic criteria were adopted in 2012 as the new international standard for the diagnosis of CRPS by the IASP and these criteria have been shown to reduce CRPS diagnostic rates by about 50% .
No other diagnosis better explains the signs and symptoms
The diagnostic criteria were designed to provide a standardized, common methodology for making decisions and discern if unidentified pain conditions represent CRPS or not. The application of inappropriate treatments due to misdiagnosis can contribute to excessive medical costs, or worse, may delay the appropriate treatment.
The distinction in CRPS-1 and CRPS-2 is made for the presence or absence of nerve lesion. A third diagnostic subtype called CRPS-NOS was recommended and it would include those patients who did not fully meet the new clinical criteria, but whose signs and symptoms could not better be explained by another diagnosis. Those patients have fewer than three symptoms or two sign categories, or do not show a sign at the time of the examination but had exhibited this previously, and whose signs and symptoms were felt to be best explained by CRPS.
The diagnosis of CRPS is based solely on clinical signs and symptoms, and for exclusion compared to other forms of chronic pain. The Budapest criteria excluded the use of imaging exams to perform the diagnosis. There are not specific diagnostic procedures and their rule is to add information to support and confirm the clinical diagnosis. Generally, the conventional plain radiography is the first exam performed and shows bone demineralization, but it is positive only in chronic stages.
An early diagnosis and an interdisciplinary approach are fundamental factors for an optimal and successful treatment.
For the first time, in 1959, Curtiss and Kincaid described a syndrome of transient demineralization of the hip in pregnant women. Since then, various terms were proposed in order to describe the common benign clinical and imaging conditions of bone marrow edema, such as regional migratory osteoporosis (RMO) and transient osteoporosis of the hip (TOH). Subsequently, these clinical entities were included under the general term of “bone marrow edema syndrome” (BMES). Now BMES represents a distinct entity with specific clinical and imaging features, but some Authors support that this syndrome should be a variant of Algodystrophy or an abortive form of osteonecrosis.
Many pathogenetic hypotheses have been proposed but the etiology of these “incomplete forms” remains unknown. Many cases are misdiagnosed due to the lack of specific symptoms and the rarity of the disease.
The main characteristic in common with CPRS is the chronic pain. Instead, characteristics missing in CPRS are: absent history of trauma or triggering events, the extremely rare involvement of the upper limbs, the absence of skin dystrophic changes and vasomotor alterations, the recurring and migrant nature and the complete restitution ad integrum (absent in cases of Algodystrophy non promptly recognized and treated).
Laboratory findings usually are not useful to the diagnosis. Standard radiographs could be normal in early phases. It can reveal bone demineralization at 3–6 weeks from the onset of the symptoms and this alteration may persist after the symptom resolution, also up to 2 years.
In the absence of clinical signs (autonomic and dystrophic changes) and radiographic examination findings, it becomes important for a correct assessment, in contrast to CRPS, to perform further investigations such as RMI and scintigraphy.
The three-phases bone scan may be positive after a few days from the onset of symptoms. Tc99m-MDP increased uptake representing focal increase in capillary permeability, hyperemia, and osteoblastic activity. MR imaging scans reveal low-signal intensity on T1-w images and high signal intensity on STIR or fat-suppressed T2-w images. These changes reflect the increased intra and extracellular fluid of the bone marrow resulting from new bone formation and repair processes. The differential diagnosis at MRI scans should be made with infection, osteonecrosis and post-traumatic marrow edema.
It is important to identify CPRS from other incomplete forms for the different evolution of the two conditions. In fact, these last are self-limited, and aggressive or surgical treatment is not needed, on the contrary CPRS, if not treated, may determine severe disability.